Loading…
Reported covered position: Legislative Fellow, Office of Senator Sherrod Brown
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Cancer Drug Parity Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Resolution designating September 2018 as "Sickle Cell Disease Awareness Month" (S.Res. 661) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions Reimbursement for CAR-T Issues impacting opioid access/use for patients with hematologic diseases and disorders
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2018 · third_quarter · Q3
CMS reimbursement for CAR-T Protect Access to Cellular Transplant (PACT) Act (H.R. 4215) Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (P.L. 114-10) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determinations Medicaid Coverage for Sickle Cell Disease Issues impacting opioid access/use for patients with hematologic diseases and disorders
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Resolution designating September 2018 as "Sickle Cell Disease Awareness Month" (S.Res. 661) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions Reimbursement for CAR-T Issues impacting opioid access/use for patients with hematologic diseases and disorders
Source: Senate LDA
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Cancer Drug Parity Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions Reimbursement for CAR-T Issues impacting opioid access/use for patients with hematologic diseases and disorders
Consolidated Appropriations Act, 2018
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2018 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ), Health Resources and Services Administration (HRSA) Public Health Program Funding Federal Research Funding H.R.195, Continuing Resolution through February 8, 2018 Bipartisan Budget Act of 2018 (H.R. 1892) Consolidated Appropriations Act, 2018 (H.R.1625)
Bipartisan Budget Act of 2018
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2018 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ), Health Resources and Services Administration (HRSA) Public Health Program Funding Federal Research Funding H.R.195, Continuing Resolution through February 8, 2018 Bipartisan Budget Act of 2018 (H.R. 1892) Consolidated Appropriations Act, 2018 (H.R.1625)
Making further continuing appropriations for the fiscal year ending September 30, 2018, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2018 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ), Health Resources and Services Administration (HRSA) Public Health Program Funding Federal Research Funding H.R.195, Continuing Resolution through February 8, 2018 Bipartisan Budget Act of 2018 (H.R. 1892) Consolidated Appropriations Act, 2018 (H.R.1625)
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative Antimicrobial Resistance (AMR) research
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Resolution designating September 2018 as "Sickle Cell Disease Awareness Month" (S.Res. 661) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions Reimbursement for CAR-T Issues impacting opioid access/use for patients with hematologic diseases and disorders
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) resolution designating September 2018 as "Sickle Cell Disease Awareness Month" (S.Res. 661) Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions Reimbursement for CAR-T Issues impacting opioid access/use for patients with hematologic diseases and disorders
Patients' Access to Treatments Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Patients' Access to Treatments Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Resolution designating September 2018 as "Sickle Cell Disease Awareness Month" (S.Res. 661) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions Reimbursement for CAR-T Issues impacting opioid access/use for patients with hematologic diseases and disorders
Patients' Access to Treatments Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions Reimbursement for CAR-T Issues impacting opioid access/use for patients with hematologic diseases and disorders
To amend title XVIII of the Social Security Act to ensure that providers of services receive adequate payments for the acquisition of hematopoietic stem cells under the Medicare program, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
CMS reimbursement for CAR-T Protect Access to Cellular Transplant (PACT) Act (H.R. 4215) Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (P.L. 114-10) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determinations Medicaid Coverage for Sickle Cell Disease Issues impacting opioid access/use for patients with hematologic diseases and disorders
To amend title XVIII of the Social Security Act to ensure that providers of services receive adequate payments for the acquisition of hematopoietic stem cells under the Medicare program, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Protect Access to Cellular Transplant (PACT) Act (H.R. 4215) Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (P.L. 114-10) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Medicaid Coverage for Sickle Cell Disease
To amend title XVIII of the Social Security Act to ensure that providers of services receive adequate payments for the acquisition of hematopoietic stem cells under the Medicare program, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
CMS reimbursement for CAR-T Protect Access to Cellular Transplant (PACT) Act (H.R. 4215) Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (P.L. 114-10) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determinations Medicaid Coverage for Sickle Cell Disease Issues impacting opioid access/use for patients with hematologic diseases and disorders
Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2019 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ), Health Resources and Services Administration (HRSA) Public Health Program Funding Federal Research Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019 (S.3158/H.R. 6570) Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (H.R. 6157)
Maintaining Commitment on the Korean Peninsula Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2019 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ), Health Resources and Services Administration (HRSA) Public Health Program Funding Federal Research Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019 (S.3158/H.R. 6570) Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (H.R. 6157)
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative Antimicrobial Resistance (AMR) research
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Resolution designating September 2018 as "Sickle Cell Disease Awareness Month" (S.Res. 661) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions Reimbursement for CAR-T Issues impacting opioid access/use for patients with hematologic diseases and disorders
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) resolution designating September 2018 as "Sickle Cell Disease Awareness Month" (S.Res. 661) Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions Reimbursement for CAR-T Issues impacting opioid access/use for patients with hematologic diseases and disorders
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2019 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ), Health Resources and Services Administration (HRSA) Public Health Program Funding Federal Research Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019 (S.3158; as yet unnumbered House Subcommittee draft bill)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2019 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ), Health Resources and Services Administration (HRSA) Public Health Program Funding Federal Research Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019 (S.3158/H.R. 6570) Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (H.R. 6157)
A resolution expressing support for the designation of September 2018 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to sickle cell disease, complications from sickle cell disease, and conditions related to sickle cell disease.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Resolution designating September 2018 as "Sickle Cell Disease Awareness Month" (S.Res. 661) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions Reimbursement for CAR-T Issues impacting opioid access/use for patients with hematologic diseases and disorders
A resolution expressing support for the designation of September 2018 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to sickle cell disease, complications from sickle cell disease, and conditions related to sickle cell disease.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) resolution designating September 2018 as "Sickle Cell Disease Awareness Month" (S.Res. 661) Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues
Making further continuing appropriations for fiscal year 2018, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2018 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ), Health Resources and Services Administration (HRSA) Public Health Program Funding Federal Research Funding Further Continuing Appropriations Act, 2018 (H.J.Res.123) (Continuing Resolution through December 22, 2017) Further Continuing Appropriations Act, 2018 (H.R. 1370) (Continuing Resolution through January 19, 2018) Further Additional Supplemental Appropriations for Disaster Relief Requirements, 2017 (H.R. 4667)
Making further continuing appropriations for fiscal year 2017, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2017 and FY 2018 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ) Public Health Program Funding Federal Research Funding Consolidated Appropriations Act 2017(H.R. 244) Making Further Continuing Appropriations for FY2017 and for other purposes (H.J.Res. 99)
An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2018 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ), Health Resources and Services Administration (HRSA) Public Health Program Funding Federal Research Funding Further Continuing Appropriations Act, 2018 (H.J.Res.123) (Continuing Resolution through December 22, 2017) Further Continuing Appropriations Act, 2018 (H.R. 1370) (Continuing Resolution through January 19, 2018) Further Additional Supplemental Appropriations for Disaster Relief Requirements, 2017 (H.R. 4667)
Cancer Drug Parity Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res. 27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Cancer Drug Parity Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Cancer Drug Parity Act (H.R. 1409) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act (H.R. 1628) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions Vaccine Safety Issues Impact of Immigration and Travel Ban Executive Order on Science/Research
Cancer Drug Parity Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act (H.R. 1628) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Cancer Drug Parity Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res. 27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Bipartisan Health Care Stabilization Act (proposed by Senators Alexander and Murray) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
American Health Care Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act (H.R. 1628) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
American Health Care Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (P.L. 114-10) American Health Care Act/Better Care Reconciliation Act (H.R. 1628) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Medicaid Coverage for Sickle Cell Disease
American Health Care Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res. 27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
American Health Care Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Protect Access to Cellular Transplant (PACT) Act (H.R. 4215) Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (P.L. 114-10) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Bipartisan Health Care Stabilization Act (proposed by Senators Alexander and Murray) CMS National Coverage Determination Medicaid Coverage for Sickle Cell Disease
American Health Care Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res. 27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Bipartisan Health Care Stabilization Act (proposed by Senators Alexander and Murray) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
American Health Care Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Cancer Drug Parity Act (H.R. 1409) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act (H.R. 1628) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions Vaccine Safety Issues Impact of Immigration and Travel Ban Executive Order on Science/Research
American Health Care Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (P.L. 114-10) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Medicaid Coverage for Sickle Cell Disease
American Health Care Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (P.L. 114-10) American Health Care Act (H.R. 1628) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations Medicaid Coverage for Sickle Cell Disease
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res. 27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res. 27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Bipartisan Health Care Stabilization Act (proposed by Senators Alexander and Murray) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act (H.R. 1628) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res.27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative
Consolidated Appropriations Act, 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2017 and FY 2018 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ) Public Health Program Funding Federal Research Funding Consolidated Appropriations Act 2017(H.R. 244) Making Further Continuing Appropriations for FY2017 and for other purposes (H.J.Res. 99)
Patients' Access to Treatments Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res. 27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Bipartisan Health Care Stabilization Act (proposed by Senators Alexander and Murray) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Patients' Access to Treatments Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res. 27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Patients' Access to Treatments Act of 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act (H.R. 1628) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
To amend title XVIII of the Social Security Act to ensure that providers of services receive adequate payments for the acquisition of hematopoietic stem cells under the Medicare program, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Protect Access to Cellular Transplant (PACT) Act (H.R. 4215) Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (P.L. 114-10) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Bipartisan Health Care Stabilization Act (proposed by Senators Alexander and Murray) CMS National Coverage Determination Medicaid Coverage for Sickle Cell Disease
Making further supplemental appropriations for the fiscal year ending September 30, 2018, for disaster assistance for Hurricanes Harvey, Irma, and Maria, and calendar year 2017 wildfires, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2018 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ), Health Resources and Services Administration (HRSA) Public Health Program Funding Federal Research Funding Further Continuing Appropriations Act, 2018 (H.J.Res.123) (Continuing Resolution through December 22, 2017) Further Continuing Appropriations Act, 2018 (H.R. 1370) (Continuing Resolution through January 19, 2018) Further Additional Supplemental Appropriations for Disaster Relief Requirements, 2017 (H.R. 4667)
Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2018 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ), Health Resources and Services Administration (HRSA) Public Health Program Funding Federal Research Funding FY 2018 Multi-Department Appropriations Act (H.R. 3354) Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (H.R. 601)
Calling for sickle-cell trait research, surveillance, and public education and awareness.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res. 27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Calling for sickle-cell trait research, surveillance, and public education and awareness.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res. 27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Bipartisan Health Care Stabilization Act (proposed by Senators Alexander and Murray) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Calling for sickle-cell trait research, surveillance, and public education and awareness.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative
Calling for sickle-cell trait research, surveillance, and public education and awareness.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res.27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative
A resolution honoring the life and achievements of Eugene A. "Gene" Cernan.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res. 27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
A resolution honoring the life and achievements of Eugene A. "Gene" Cernan.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res.27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative
A resolution honoring the life and achievements of Eugene A. "Gene" Cernan.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res. 27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Bipartisan Health Care Stabilization Act (proposed by Senators Alexander and Murray) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Advancing Hope Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Sickle Cell Disease/Trait Issues Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative Regulation of laboratory developed tests Cancer "Moonshot" initiative
Advancing Hope Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Resolution expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" (S.Res. 592/H.Res. 903) Sickle Cell Disease/Trait Issues Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests Cancer "Moonshot" initiative
Advancing Hope Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Advancing Hope Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Resolution expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" (S.Res. 592/H.Res. 903) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Patients' Access to Treatments Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Resolution expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" (S.Res. 592/H.Res. 903) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Patients' Access to Treatments Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Patients' Access to Treatments Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Resolution expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" (S.Res. 592/H.Res. 903) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Sickle Cell Disease/Trait Issues Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative Regulation of laboratory developed tests Cancer "Moonshot" initiative
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Resolution expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" (S.Res. 592/H.Res. 903) Sickle Cell Disease/Trait Issues Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests Cancer "Moonshot" initiative
Further Continuing and Security Assistance Appropriations Act, 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Further Continuing and Security Assistance Appropriations Act (H.R.2028) FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention (S.3040, H.R. 5926) Public Health Program Funding 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Resolution expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" (S.Res. 592/H.Res. 903) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Sickle Cell Disease/Trait Issues Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative Regulation of laboratory developed tests Cancer "Moonshot" initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Further Continuing and Security Assistance Appropriations Act (H.R.2028) FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention (S.3040, H.R. 5926) Public Health Program Funding 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative
Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2017 Legislative Branch Appropriations Act/Continuing Resolution through December 9, 2016 (H.R. 5325) FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention (S.3040, H.R. 5926) Public Health Program Funding 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Further Continuing and Security Assistance Appropriations Act (H.R.2028) FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention (S.3040, H.R. 5926) Public Health Program Funding 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2017 Legislative Branch Appropriations Act/Continuing Resolution through December 9, 2016 (H.R. 5325) FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention (S.3040, H.R. 5926) Public Health Program Funding 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests Cancer "Moonshot" initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2017 Legislative Branch Appropriations Act/Continuing Resolution through December 9, 2016 (H.R. 5325) FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention (S.3040, H.R. 5926) Public Health Program Funding 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Resolution expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" (S.Res. 592/H.Res. 903) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Sickle Cell Disease/Trait Issues Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative Regulation of laboratory developed tests Cancer "Moonshot" initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention (S.3040) Public Health Program Funding 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Further Continuing and Security Assistance Appropriations Act (H.R.2028) FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention (S.3040, H.R. 5926) Public Health Program Funding 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Resolution expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" (S.Res. 592/H.Res. 903) Sickle Cell Disease/Trait Issues Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests Cancer "Moonshot" initiative
Expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to sickle cell disease.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Resolution expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" (S.Res. 592/H.Res. 903) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to sickle cell disease.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Resolution expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" (S.Res. 592/H.Res. 903) Sickle Cell Disease/Trait Issues Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests Cancer "Moonshot" initiative
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Resolution expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" (S.Res. 592/H.Res. 903) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) resolution designating September 2018 as "Sickle Cell Disease Awareness Month" (S.Res. 661) Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues
FY 2019 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ), Health Resources and Services Administration (HRSA) Public Health Program Funding Federal Research Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019 (S.3158/H.R. 6570) Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (H.R. 6157)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2018 · second_quarter · Q2
FY 2019 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ), Health Resources and Services Administration (HRSA) Public Health Program Funding Federal Research Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019 (S.3158; as yet unnumbered House Subcommittee draft bill)
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions Reimbursement for CAR-T Issues impacting opioid access/use for patients with hematologic diseases and disorders
CMS reimbursement for CAR-T Protect Access to Cellular Transplant (PACT) Act (H.R. 4215) Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (P.L. 114-10) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determinations Medicaid Coverage for Sickle Cell Disease Issues impacting opioid access/use for patients with hematologic diseases and disorders
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2018 · first_quarter · Q1
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018 (S. 2465) Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative Antimicrobial Resistance (AMR) research
FY 2018 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ), Health Resources and Services Administration (HRSA) Public Health Program Funding Federal Research Funding H.R.195, Continuing Resolution through February 8, 2018 Bipartisan Budget Act of 2018 (H.R. 1892) Consolidated Appropriations Act, 2018 (H.R.1625)
Protect Access to Cellular Transplant (PACT) Act (H.R. 4215) Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (P.L. 114-10) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Medicaid Coverage for Sickle Cell Disease
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2017 · fourth_quarter · Q4
FY 2018 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ), Health Resources and Services Administration (HRSA) Public Health Program Funding Federal Research Funding Further Continuing Appropriations Act, 2018 (H.J.Res.123) (Continuing Resolution through December 22, 2017) Further Continuing Appropriations Act, 2018 (H.R. 1370) (Continuing Resolution through January 19, 2018) Further Additional Supplemental Appropriations for Disaster Relief Requirements, 2017 (H.R. 4667)
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative
Protect Access to Cellular Transplant (PACT) Act (H.R. 4215) Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (P.L. 114-10) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Bipartisan Health Care Stabilization Act (proposed by Senators Alexander and Murray) CMS National Coverage Determination Medicaid Coverage for Sickle Cell Disease
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res. 27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Bipartisan Health Care Stabilization Act (proposed by Senators Alexander and Murray) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2017 · third_quarter · Q3
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res.27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative
FY 2018 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ), Health Resources and Services Administration (HRSA) Public Health Program Funding Federal Research Funding FY 2018 Multi-Department Appropriations Act (H.R. 3354) Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (H.R. 601)
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) H.Res. 539, Calling for sickle-cell trait research, surveillance, and public education and awareness S.Res. 27, Designating September 2017 as "Sickle Cell Disease Awareness Month" Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (P.L. 114-10) American Health Care Act/Better Care Reconciliation Act/Health Care Freedom Act (H.R. 1628) Graham-Cassidy-Heller-Johnson Amendment re: ACA repeal/reform Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Medicaid Coverage for Sickle Cell Disease
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2017 · second_quarter · Q2
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Cancer Drug Parity Act (H.R. 1409) Patients Access to Treatment Act (H.R. 2999) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act/Better Care Reconciliation Act (H.R. 1628) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (P.L. 114-10) American Health Care Act/Better Care Reconciliation Act (H.R. 1628) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Medicaid Coverage for Sickle Cell Disease
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2017 · first_quarter · Q1
Sickle Cell Disease/Trait Issues Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative
FY 2017 and FY 2018 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ) Public Health Program Funding
Cancer Drug Parity Act (H.R. 1409) Implementation of Patient Protection and Affordable Care Act (P.L. 111-148) Repeal of Patient Protection and Affordable Care Act (P.L. 111-148) American Health Care Act (H.R. 1628) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Issues Impacting Coverage for Hematologic Diseases and Conditions Vaccine Safety Issues Impact of Immigration and Travel Ban Executive Order on Science/Research
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2016 · fourth_quarter · Q4
Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Further Continuing and Security Assistance Appropriations Act (H.R.2028) FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention (S.3040, H.R. 5926) Public Health Program Funding 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2016 · third_quarter · Q3
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Resolution expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" (S.Res. 592/H.Res. 903) Sickle Cell Disease/Trait Issues Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests Cancer "Moonshot" initiative
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2016 · second_quarter · Q2
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests Cancer "Moonshot" initiative
FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention (S.3040) Public Health Program Funding 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
FY 2017 and FY 2018 Funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ) Public Health Program Funding Federal Research Funding Consolidated Appropriations Act 2017(H.R. 244) Making Further Continuing Appropriations for FY2017 and for other purposes (H.J.Res. 99)
Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (P.L. 114-10) American Health Care Act (H.R. 1628) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations Medicaid Coverage for Sickle Cell Disease
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), President of the U.S., SENATE, Veterans Affairs, Dept of (VA)
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Sickle Cell Disease/Trait Issues Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative Regulation of laboratory developed tests Cancer "Moonshot" initiative
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of the Vice President of the United States, SENATE, Veterans Affairs, Dept of (VA)
FY 2017 Legislative Branch Appropriations Act/Continuing Resolution through December 9, 2016 (H.R. 5325) FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention (S.3040, H.R. 5926) Public Health Program Funding 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Resolution expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" (S.Res. 592/H.Res. 903) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of the Vice President of the United States, SENATE, Veterans Affairs, Dept of (VA)
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of the Vice President of the United States, SENATE, Veterans Affairs, Dept of (VA)